Skip to main content
Log in

Protein Kinase C Blockade Inhibits Differentiation of Myeloid Blasts into Dendritic Cells by Calcium Ionophore A23187

  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

Direct differentiation of myeloid leukemia blasts into antigen-presenting dendritic cells (DCs) for use as cellular vaccines is unique in that identification of tumor-specific antigens may not be necessary because the antigens should already be endogenously expressed.We hypothesized that signaling through protein kinase C (PKC) is required for differentiation of HL-60 promyeloblasts into DCs upon stimulation with calcium ionophore A23187. To demonstrate the inhibitory effect of PKC blockade, we pretreated HL-60 myeloid blasts with the protein kinase inhibitor bisindolylmaleimide I (Bis-1) for 24 hours and then treated the cells with calcium ionophore A23187 for an additional 24 hours. Controls consisted of HL-60 blasts treated with A23187, Bis-1 alone, or media.We noted that blasts cultured in media, Bis-1, or Bis-1 then A23187 did not develop the morphologic and phenotypic DC characteristics, up-regulate Rel B, or activate allogeneic T-cells. Our findings suggested that PKC blockade inhibits morphologic, phenotypic, and functional differentiation of HL-60 promyeloblasts into antigen-presenting DCs. Our findings supported the role of PKC as an obligatory pathway for calcium ionophore A23187-induced differentiation of HL-60 myeloblasts into antigen-presenting DCs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Timmerman JM, Levy R. Dendritic cell vaccines for cancer immunotherapy. Annu Rev Med. 1999;50:507–529.

    Article  CAS  PubMed  Google Scholar 

  2. Fong L, Engleman EG. Dendritic cells in cancer immunotherapy. Annu Rev Immunol. 2000;18:245–273.

    Article  CAS  PubMed  Google Scholar 

  3. Banchereau J, Briere F, Caux C, et al. Immunobiology of dendritic cells. Annu Rev Immunol. 2000;18:767–811.

    Article  CAS  PubMed  Google Scholar 

  4. Tarte K, Klein B. Dendritic cell-based vaccine: a promising approach for cancer immunotherapy. Leukemia. 1999;13:653–663.

    Article  PubMed  CAS  Google Scholar 

  5. St. Louis DC, Woodcock JB, Fransozo G, et al. Evidence for distinct intracellular signaling pathways in CD34+ progenitor to dendritic cell differentiation from a human cell line model. J Immunol. 1999;162:3237–3248.

    PubMed  CAS  Google Scholar 

  6. Davis TA, Saini AA, Blair PJ, et al. Phorbol esters induce differentiation of human CD34+ hemopoietic progenitors to dendritic cells: evidence for protein kinase C-mediated signaling. J Immunol. 1998;160:3689–3697.

    PubMed  CAS  Google Scholar 

  7. Choudhury BA, Liang JC, Thomas EK, et al. Dendritic cells derived in vitro from acute myelogenous leukemia cells stimulate autologous, anti-leukemic T-cell responses. Blood. 1999;93:780–786.

    CAS  PubMed  Google Scholar 

  8. Czerniecki BJ, Carter C, Rivoltini L, et al. Calcium ionophoretreated peripheral blood monocytes and dendritic cells rapidly display characteristics of activated dendritic cells. J Immunol. 1997;159:3823–3837.

    PubMed  CAS  Google Scholar 

  9. Koski GK, Schwartz GN, Weng DE, et al. Calcium mobilization in human myeloid cells results in acquisition of individual dendritic cell-like characteristics through discrete signaling pathways. J Immunol. 1999;163:82–92.

    PubMed  CAS  Google Scholar 

  10. Engels FH, Kreisel D, Faries MB, et al. Calcium ionophore activation of chronic myelogenous leukemia progenitor cells into dendritic cells is mediated by calcineurin phosphatase. Leukemia Res. 2000;24:795–804.

    Article  CAS  Google Scholar 

  11. Waclavicek M, Berer A, Oehler L, et al. Calcium ionophore: a single reagent for the differentiation of primary human acute myelogenous leukaemia cells towards dendritic cells. Br J Haematol. 2001;114:466–473.

    Article  PubMed  CAS  Google Scholar 

  12. Toker A. Protein kinases as mediators of phosphoinositide 3- kinase signaling. Mol Pharmacol. 2000;57:652–658.

    Article  PubMed  CAS  Google Scholar 

  13. Toker A. Signaling through protein kinase C. Front Biosci. 1998;3: D1134-D1147.

    Article  PubMed  CAS  Google Scholar 

  14. LaPorte DC, Wierman BM, Storm DR. Calcium-induced exposure of a hydrophobic surface on calmodulin. Biochemistry. 1980;19:3814–3819.

    Article  CAS  PubMed  Google Scholar 

  15. Kuznicki J, Grabarek Z, Brzeska H, Drabikowski W, Cohen P. Stimulation of enzyme activities by fragments of calmodulin. FEBS Lett. 1981;130:141–145.

    Article  PubMed  CAS  Google Scholar 

  16. Simms PE, Ellis TM. Utility of flow cytometric detection of CD69 expression as a rapid method for determining poly- and oligoclonal lymphocyte activation. Clin Diagn Lab Immunol. 1996;3:301–304.

    PubMed  PubMed Central  CAS  Google Scholar 

  17. June CH, Ledbetter JA, Gillespie MM, Lindsten T, Thompson CB. T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression. Mol Cell Biol. 1987;12:4472–4481.

    Article  Google Scholar 

  18. Burkly L, Hession C, Ogata L, et al. Expression of relB is required for the development of thymic medulla and dendritic cells. Nature. 1995;373:531–536.

    Article  PubMed  CAS  Google Scholar 

  19. O’Sullivan BJ, MacDonald KP, Pettit AR, Thomas R. RelB nuclear translocation regulates B cell MHC molecule, CD40 expression, and antigen-presenting cell function. Proc Natl Acad Sci U S A. 2000;97:11421–11426.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Lindner I, Kharfan-Dabaja MA, Ayala E, et al. Induced dendritic cell differentiation of chronic myeloid leukemia blasts is associated with down-regulation of BCR-ABL. J Immunol. 2003;171:1780–1791.

    Article  PubMed  CAS  Google Scholar 

  21. Groux H, Fournier N, Cottrez F. Role of dendritic cells in the generation of regulatory T cells. Semin Immunol. 2004;16:99–106.

    Article  PubMed  CAS  Google Scholar 

  22. Quah B, Ni K, O’Neill HC. In vitro hematopoiesis produces a distinct class of immature dendritic cells from spleen progenitors with limited T cell stimulation capacity. Int Immunol. 2004;16:567–577.

    Article  PubMed  CAS  Google Scholar 

  23. Jung CW, Kwon JH, Seol JG, et al. Induction of cytotoxic T lymphocytes by dendritic cells pulsed with murine leukemic cell RNA. Am J Hematol. 2004;75:121–127.

    Article  PubMed  CAS  Google Scholar 

  24. Minami T, Nakanishi Y, Izumi M, Harada T, Hara N. Enhancement of antigen-presenting capacity and antitumor immunity of dendritic cells pulsed with autologous tumor-derived RNA in mice. J Immunother. 2003;26:420–431.

    Article  PubMed  CAS  Google Scholar 

  25. Schmidt T, Ziske C, Marten A, et al. Intratumoral immunization with tumor RNA-pulsed dendritic cells confers antitumor immunity in a C57BL/6 pancreatic murine tumor model. Cancer Res. 2003;63:8962–8967.

    PubMed  CAS  Google Scholar 

  26. Westers TM, Stam AM, Scheper RM, et al. Rapid generation of antigen-presenting cells from leukaemic blasts in acute myeloid leukaemia. Cancer Immunol Immunother. 2003;52:17–27.

    Article  PubMed  CAS  Google Scholar 

  27. Roddie PH, Horton Y, Turner ML. Primary acute myeloid leukaemia blasts resistant to cytokine-induced differentiation to dendritic-like leukaemia cells can be forced to differentiate by the addition of bryostatin-1. Leukemia. 2002;16:84–93.

    Article  PubMed  CAS  Google Scholar 

  28. Jonuleit H, Kuhn U, Muller G, et al. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol. 1997;27:3135–3142.

    Article  PubMed  CAS  Google Scholar 

  29. Charbonnier A, Gaugler B, Sainty D, et al. Human acute myeloblastic leukemia cells differentiate in vitro into mature dendritic cells and induce the differentiation of cytotoxic T cells against autologous leukemias. Eur J Immunol. 1999;29:2567–2578.

    Article  CAS  PubMed  Google Scholar 

  30. Gekeler V, Boer R, Uberall F, et al. Effects of the selective bisindolylmaleimide protein kinase C inhibitor GF 109203X on P-glycoprotein- mediated multidrug resistance. Br J Cancer. 1996;74:897–905.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mohamed A. Kharfan-Dabajaa.

About this article

Cite this article

Li, Q., Ozer, H., Lindner, I. et al. Protein Kinase C Blockade Inhibits Differentiation of Myeloid Blasts into Dendritic Cells by Calcium Ionophore A23187. Int J Hematol 81, 131–137 (2005). https://doi.org/10.1532/IJH97.NA0405

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1532/IJH97.NA0405

Key words

Navigation